Showing results (251-260 of 458) with videos related to

Sort By:
Pageof 46
Pediatric Blood & Cancer|January 22, 2013
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing programStephen T Keir, John M Maris, C Patrick Reynolds, et al.
Blood|June 8, 2006
Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS)David T Teachey, Dana A Obzut, Kelly Axsom, et al.
Pediatric Blood & Cancer|June 26, 2009
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing programRichard Gorlick, E Anders Kolb, Peter J Houghton, et al.
Pediatric Blood & Cancer|April 5, 2013
Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, C Patrick Reynolds, et al.
Scientific Data|April 15, 2020
Epigenomic profiling of neuroblastoma cell linesKristen Upton, Apexa Modi, Khushbu Patel, et al.
Pediatric Blood & Cancer|June 17, 2009
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COGChizuko Okamatsu, Wendy B London, Arlene Naranjo, et al.
Plos Genetics|December 21, 2016
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma GenomeOlivia M Padovan-Merhar, Pichai Raman, Irina Ostrovnaya, et al.
STAR Protocols|August 30, 2025
Protocol for plasma membrane enrichment by ultracentrifugation for mass spectrometry of cell lines, xenografts, and patient tumorsAmber K Hamilton, Brian Mooney, Tina Glisovic-Aplenc, et al.
Frontiers in Bioscience : a Journal and Virtual Library|August 7, 2001
Nonmyeloablative hematopoietic stem cell transplantation: transplantation for the 21st centuryM Maris, A Woolfrey, P A McSweeney, et al.
Pediatric Blood & Cancer|July 4, 2012
Initial testing of the MDM2 inhibitor RG7112 by the Pediatric Preclinical Testing ProgramHernan Carol, C Patrick Reynolds, Min H Kang, et al.
Pageof 46